VTI is a global company dedicated to improving vision through a comprehensive product portfolio including the NaturalVue brand of contact lenses and quality control is one of the most important aspects of the company’s responsibilities.
“Craig’s background makes him an ideal match for our company,” said Brian Lane, chief financial officer. “He brings significant knowledge of the quality role which is critical to VTI’s growth in the near future. We are happy to have him as a part of our team.”
Johnson brings more than 25 years of experience working in U.S. Food and Drug Administration (FDA) regulated environments, including FDA inspection interaction. Before joining VTI, he was in quality assurance with CryoLife. Prior to that he served in various quality roles for Kimberly-Clark Corporation.
Johnson earned his bachelor of science degree in mathematics from Alabama State University and his master’s degree in business administration from the University of North Alabama. He is also an ASQ Certified Quality Auditor, Quality Engineer, a Certified Six Sigma Green Belt and a Certified Biomedical Auditor.
“I am excited to be a member of the Visioneering Technologies team where all employees set quality as a primary standard in every aspect of the daily work. With quality as a primary standard, we will definitely continue making positive impacts on the patients that will ultimately use our products,” said Johnson.
Visioneering Technologies Inc. is an eye care company committed to redefining vision. Since its founding in 2008, Visioneering has brought together clinical, marketing, engineering, manufacturing and regulatory leaders from top vision care businesses to provide new solutions for presbyopia, myopia and astigmatism. Headquartered in the United States, Visioneering designs, manufactures, sells, and distributes contact lenses. Its flagship product is the NaturalVue Multifocal contact lens, and VTI has expanded its portfolio of technologies to address a range of eye care issues. The company has grown operations across the United States, Australia, and Europe, and is expanding into Asia with a focus on markets with high rates of myopia.